HER2 + BREAST CANCER
Clinical trials for HER2 + BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation boost may supercharge immunotherapy in breast cancer
Disease control OngoingThis early-phase trial tests whether adding a single, focused dose of radiation before surgery can make the immunotherapy drug pembrolizumab work better in people with early-stage breast cancer. About 27 participants will receive both treatments, then have surgery to see if the t…
Matched conditions: HER2 + BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a simple blood test tell some breast cancer patients It's safe to stop treatment?
Knowledge-focused OngoingThis study is for people with HER2-positive metastatic breast cancer who have had a lasting response (complete or partial remission for over 2 years) on anti-HER2 therapy. Researchers will use a personalized blood test called Signatera to look for tiny amounts of cancer DNA. The …
Matched conditions: HER2 + BREAST CANCER
Sponsor: Nagoya City University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC